23 April 2022: Clinical Research
Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
Liying Han 1CEF , Guanyong He 1CDE , Yingjie Mei 2CD , Qing Yu 3BF , Minning Zhao 3BF , Fu Luo 4B , Guanxun Cheng 1AEG** , Wen Liang 3AE**DOI: 10.12659/MSM.935307
Med Sci Monit 2022; 28:e935307
Figure 4 (A)The calibration curve based on internal validation. The blue dotted line represents the performance of the ideal model. The red and green solid lines represent the performance of the combined model without and with bias correction. (B) Decision curves show that the combined model (prostate-specific antigen density [PSAD]+apparent diffusion coefficient [ADC]) added more benefit over ADC, PSAD, and PI-RADS v2 in a wide range threshold of probability. (R 4.0.3, The R Foundation for Statistical Computing).